Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2018

View Archived Issues

FDA awards fast track designation to Cour Pharmaceuticals' candidate for celiac disease

Positive efficacy data for Modufolin as first-line treatment in patients with mCRC

FDA approves Lynparza for BRCA-mutated metastatic breast cancer

FDA grants fast track designation to CTP-543 for moderate to severe alopecia areata

AnaptysBio: treating severe inflammatory diseases

Novel nanotherapeutic targets both miR-34a and PLK1 for pancreatic cancer

X4 Pharmaceuticals divulges new CXCR-4 inhibitors for cancer

Medshine Discovery patents beta-lactamase inhibitors

Novel hEED inhibitors presented by Novartis

Bayer discloses new menin/MLL interaction inhibitors

Sunshine Lake Pharma divulges compounds for depression

SBIR grant supports work at Sci-Engi-Medco in preclinical models of breast cancer

Ingestible sensors transmit data on chemical composition of the gut

European Commission approves Adynovi for hemophilia A

Zhejiang Hisun Pharmaceutical identifies GCGR antagonists

Topline results from Japanese phase III study of JTE-052 in atopic dermatitis

Avacta and Glythera sign licensing deal following successful proof-of-concept study

Toray and 3SBio enter license agreement for orally disintegrating formulation of TRK-820 in China

LIDDS reports new findings on NanoZolid technology in additional cancer model

FDA accepts NDA for IDP-121 lotion for acne

GeneDx enters research collaboration with the Radboud University

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...